Michael Treadway, Sarah Etuk, Jessica Cooper, Shabnam Hossein, Emma Hahn, Samantha Betters, Shiyin Liu, Amanda Arulpragasam, Brittany DeVries, Nadia Irfan, Makiah Nuutinen, Evanthia Wommack, Bobbi Woolwine, Mandakh Bekhbat, Philip Kragel, Jennifer Felger, Ebrahim Haroon, Andrew Miller
Chronic, low-grade inflammation has been associated with motivational deficits in patients with major depression (MD). In turn, impaired motivation has been linked to poor quality of life across psychiatric disorders. We thus determined effects of the anti-inflammatory drug infliximab-a potent tumor necrosis factor (TNF) antagonist-on behavioral and neural measures of motivation in 42 medically stable, unmedicated MD patients with a C-reactive protein > 3mg/L. All patients underwent a double-blind, placebo-controlled, single-dose, randomized clinical trial with infliximab (5mg/kg) versus placebo...
March 5, 2024: Research Square